BCR and diffuse large B-cell lymphoma: In ABC subtype/non-GCB subtype of DLBCL, active B-cell receptor (BCR) signaling results in inhibition of apoptosis, thereby promoting uncontrolled cell division thus resulting in disease progression (PD), or can be responsible for insensitivity against chemotherapy (20–22).